Immunogenicity and safety to SARS-Cov-2 vaccination in patients with systemic vasculitis
Background/objectivesPatients with systemic vasculitis faced the risk of severe COVID-19 and high mortality during the pandemic. Although SARS-CoV-2 vaccination mitigates these outcomes, vaccine hesitancy persists, and data on immunogenicity and safety…